Overview

Effects of Glucagon Like Peptide-1 on No-reflow

Status:
Unknown status

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

The investigators planned to evaluate the effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction (STEMI).

Phase:

N/A

Details

Lead Sponsor:

Chen Wei Ren, MD

Treatments:

Glucagon
Glucagon-Like Peptide 1
Liraglutide